Journal of Clinical Oncology, Vol 20, Issue 7
(April), 2002: 1826-1831
© 2002 American Society for Clinical Oncology
Tumor Vascularity in the Prognostic Assessment of Primary Cutaneous Melanoma
By Mohammed Kashani-Sabet,
Richard W. Sagebiel,
Carlos M.M. Ferreira,
Mehdi Nosrati,
James R. Miller, III
From the Melanoma Center, Cutaneous Oncology Program, Cancer Center, University of California at San Francisco, San Francisco, CA.
Address reprint requests to Richard W. Sagebiel, MD, University of California at San Francisco Cancer Center, 1600 Divisadero St, Fourth Floor, San Francisco, CA 94115; email: moledoc{at}itsa.ucsf.edu
PURPOSE: The vascular supply of the primary tumor is recognized to play an important role in the progression of a number of solid tumors. However, the role of tumor vascularity in the prognostic assessment of melanoma remains unclear. The purpose of this study was to determine the prognostic impact of patterns of vascularity on the outcome associated with cutaneous melanoma.
PATIENTS AND METHODS: Tumor vascularity was documented prospectively using routine histopathologic analysis of 417 primary cutaneous melanomas from the University of California at San Francisco Melanoma Center database. Four patterns of tumor vascularity were recorded: absent, sparse, moderate, and prominent.
RESULTS: Increasing tumor vascularity significantly increased the risk of relapse and death associated with melanoma, corresponding to reduced relapse-free and overall survival. By multivariate analysis, tumor vascularity was the most important determinant of overall survival, surpassing tumor thickness. Increasing tumor vascularity was associated with increased incidence of ulceration in the primary tumor.
CONCLUSION: Tumor vascularity is an important prognostic factor in melanoma, rivaling tumor thickness. Increasing tumor vascularity is highly correlated with ulceration, possibly helping to explain the biologic basis of this known prognostic factor.
Presented in part at the Thirty-Seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, CA, May 12-15, 2001.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kashani-Sabet, S. Venna, M. Nosrati, J. Rangel, A. Sucker, F. Egberts, F. L. Baehner, J. Simko, S. P.L. Leong, C. Haqq, et al.
A Multimarker Prognostic Assay for Primary Cutaneous Melanoma
Clin. Cancer Res.,
November 15, 2009;
15(22):
6987 - 6992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Thompson, F. S. Hodi, and A. Zembowicz
Case 2-2007 -- A 49-Year-Old Woman with a Pigmented Lesion on the Arm
N. Engl. J. Med.,
January 18, 2007;
356(3):
285 - 292.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rangel, S. Torabian, L. Shaikh, M. Nosrati, F. L. Baehner, C. Haqq, S. P.L. Leong, J. R. Miller III, R. W. Sagebiel, and M. Kashani-Sabet
Prognostic Significance of Nuclear Receptor Coactivator-3 Overexpression in Primary Cutaneous Melanoma
J. Clin. Oncol.,
October 1, 2006;
24(28):
4565 - 4569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Shaikh, R. W. Sagebiel, C. M. M. Ferreira, M. Nosrati, J. R. Miller III, and M. Kashani-Sabet
The Role of Microsatellites as a Prognostic Factor in Primary Malignant Melanoma
Arch Dermatol,
June 1, 2005;
141(6):
739 - 742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S.A. Qadri, J.-H. Wang, J. C. Coffey, M. Alam, A. O'Donnell, T. Aherne, and H. P. Redmond
Surgically Induced Accelerated Local and Distant Tumor Growth is Significantly Attenuated by Selective COX-2 Inhibition
Ann. Thorac. Surg.,
March 1, 2005;
79(3):
990 - 995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kashani-Sabet, L. Shaikh, J. R. Miller III, M. Nosrati, C. M.M. Ferreira, R. J. Debs, and R. W. Sagebiel
NF-{kappa}B in the Vascular Progression of Melanoma
J. Clin. Oncol.,
February 15, 2004;
22(4):
617 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|